Lorazepam: Clinical Trials

23 trials of Lorazepam, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

13 completed, 3 terminated, 3 withdrawn, 2 active not recruiting. 23 Phase 2, 5 Phase 3, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 223Completed 13, Terminated 3, Withdrawn 3, Active not recruiting 2, Recruiting 1, Unknown 1
Phase 35Completed 2, Active not recruiting 1, Recruiting 1, Withdrawn 1
Phase 11Withdrawn 1

Follow Lorazepam: new trials by email Literature Review of Lorazepam trials Research Report on Lorazepam

Trials (filtered) newest first · largest first

All 23 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Prescribing Lorazepam for IUD Insertion: Pilot Feasibility Study
Lorazepam 1 mg, Ibuprofen 800 mg - Pain, IUD
Phase 2WithdrawnUniversity of Wisconsin, Madison2025-10-012025-10-30
Acute Agitation in Emergency Psychiatry
Sublingual Dexmedetomidine, Buccal midazolam, Oral lorazepam - Agitation
Phase 2 / Phase 3RecruitingLone Baandrup1322024-12-302025-01-01
Therapies for Down Syndrome Regression Disorder
Lorazepam, Intravenous immunoglobulin (IVIG), Tofacitinib - Down Syndrome, Regression
Phase 2CompletedUniversity of Colorado, Denver662023-06-292026-09-03
Meth-OD: A Study of IXT-m200 in Patients With Toxicity From Methamphetamine Overdose
IXT-m200, Lorazepam, Haloperidol - Methamphetamine Intoxication (Disorder)
Phase 2TerminatedInterveXion Therapeutics, LLC202021-06-302023-11-18
Lorazepam for the Analgosedation of Pediatric Patients in Mechanical Ventilation.
Lorazepam 4 mg/ml - Analgesia
Phase 2UnknownBambino Gesù Hospital and Research Institute92020-12-012020-11-27
Haloperidol and Lorazepam in Controlling Symptoms of Persistent Agitated Delirium in Patients With Advanced Cancer Undergoing Palliative Care
Haloperidol, Lorazepam, Placebo - Delirium, Locally Advanced Malignant Neoplasm
Phase 2 / Phase 3Active not recruitingM.D. Anderson Cancer Center1102019-07-172026-06-15
Benzodiazepines for the Reduction of Distress and Pain During and After Emergency Department Care
Placebos, Lorazepam - Acute Pain
Phase 2TerminatedMaria Pacella12019-01-252020-03-09
Effect of A Single Dose of Lorazepam on Salivary Cortisol Response in Children Undergoing Digestive Endoscopy:
Lorazepam, Placebo - Anxiety
Phase 2CompletedSt. Justine's Hospital982017-06-282018-09-05
A Study to Assess the Efficacy and Safety of Brivaracetam as Treatment for Increased Seizure Activity in an Epilepsy Monitoring Unit Setting
Brivaracetam, Lorazepam - Epilepsy
Phase 2CompletedUCB Biopharma S.P.R.L.462017-02-062020-12-16
PF-06372865 in Subjects With Photosensitive Epilepsy
PF-06372865, Placebo, Lorazepam - Reflex Epilepsy, Photosensitive
Phase 2CompletedPfizer72015-12-162018-03-14
Haloperidol and Lorazepam for Delirium in Patients With Advanced Cancer
Lorazepam, Placebo, Haloperidol decanoate - Advanced Cancers
Phase 2Active not recruitingM.D. Anderson Cancer Center932014-01-012026-07-17
Sunitinib or Cediranib for Alveolar Soft Part Sarcoma
Cediranib, Sunitinib, Prochlorperazine - Sarcoma, Alveolar Soft Part
Phase 2CompletedNational Cancer Institute (NCI)342011-07-182026-02-02
Glutamatergic Modulation of Cocaine-related Deficits
Ketamine 0.41 mg/kg, Ketamine 0.71 mg/kg, Lorazepam 2 mg - Cocaine Dependence
Phase 2CompletedNew York State Psychiatric Institute82011-02-012019-04-30
Proof of Concept in Patients With Generalized Anxiety Disorder (GAD)AZD7325
AZD7325, Lorazepam, Placebo - Anxiety Disorders
Phase 2CompletedAstraZeneca3692008-12-012010-10-08
Efficacy and Safety Study Comparing Lorazepam and Diazepam for Children in the Emergency Department With Seizures (Status 2)
lorazepam or diazepam - Status Epilepticus
Phase 2 / Phase 3CompletedEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)2592008-02-012012-12-18
Seizure Therapy With Intravenous Levetiracetam and Lorazepam
Levetiracetam 1 g IV + Lorazepam 2 mg IV, Placebo + Lorazepam 3 mg IV - Seizures
Phase 2 / Phase 3WithdrawnMassachusetts General Hospital2008-01-012012-11-01
Diphenhydramine, Lorazepam, and Dexamethasone in Treating Nausea and Vomiting Caused By Chemotherapy
Decadron®, Benadryl®, Ativan® - Nausea, Vomiting
Phase 2TerminatedUniversity of South Florida72007-10-012014-07-25
Effects of Pentazocine Versus Lorazepam on Manic Symptoms
Pentazocine, Lorazepam - Bipolar Disorder, Schizoaffective Disorder
Phase 2CompletedMclean Hospital192007-01-012019-03-06
Lorazepam Sedation for Critically Ill Children
Lorazepam, Midazolam, Lorazepam CI - Critical Illness
Phase 2 / Phase 3CompletedThe Emmes Company, LLC1792004-09-012023-03-20
MENDS Study: Trial in Ventilated ICU Patients Comparing an Alpha2 Agonist Versus a Gamma Aminobutyric Acid (GABA)-Agonist to Determine Delirium Rates, Efficacy of Sedation, Analgesia and Discharge Cognitive Status
Dexmedetomidine, Lorazepam - Delirium
Phase 2CompletedVanderbilt University1002004-08-012018-09-11

Showing 20 of 23. Sign in to see all of them.

Conditions studied

Delirium (3)  ·  Anxiety Disorders (2)  ·  Acute Pain (1)  ·  Agnosia (1)  ·  Alcoholism (1)  ·  Autoimmune Diseases (1)  ·  Autoimmune Diseases of the Nervous System (1)  ·  Bipolar Disorder (1)  ·  Catatonia (1)  ·  Cocaine-Related Disorders (1)  ·  Cognitive Dysfunction (1)  ·  Critical Illness (1)  ·  Down Syndrome (1)  ·  Epilepsy (1)  ·  Epilepsy, Reflex (1)

Sponsors

M.D. Anderson Cancer Center (2)  ·  National Institute on Alcohol Abuse and Alcoholism (NIAAA) (2)  ·  AstraZeneca (1)  ·  Bambino Gesù Hospital and Research Institute (1)  ·  Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1)  ·  InterveXion Therapeutics, LLC (1)  ·  Lone Baandrup (1)  ·  Maria Pacella (1)  ·  Massachusetts General Hospital (1)  ·  Mclean Hospital (1)  ·  National Cancer Institute (NCI) (1)  ·  New York State Psychiatric Institute (1)  ·  Pfizer (1)  ·  St. Justine's Hospital (1)  ·  The Emmes Company, LLC (1)

Countries

United States (19)  ·  Canada (2)  ·  Brazil (1)  ·  Denmark (1)  ·  Puerto Rico (1)

Top investigators

Alice P Chen, M.D. (1)  ·  Beth L Murphy, MD/PhD (1)  ·  Carl Hart, PhD (1)  ·  Carrie Randall, PhD (1)  ·  David Hui (1)  ·  David Hui, MD (1)  ·  E Wesley Ely, MD, MPH (1)  ·  Elias Dakwar, MD (1)  ·  Elise Sannar, MD (1)  ·  Haydar Frangoul, MD (1)  ·  James Chamberlain, MD (1)  ·  Jeffrey L Blumer, MD, PhD (1)  ·  Jensena Carlson, MD (1)  ·  Joaquin Espinosa, PhD (1)

Results publications

PMID 18073360, PMID 20233428, PMID 24035344, PMID 24756515, PMID 27993298, PMID 28975307, PMID 29363356, PMID 30877186, PMID 31418168, PMID 36302173, PMID 40742738

NIH funding

2019 (1), 2023 (1), K23DA014291 (1), R21CA186000 (1), U01DA053043 (1), U10CA081920 (1)